Shikhar Sharma, Ph.D.
Affiliations: | 2010 | Genetic, Molecular, and Cell Biology | University of Southern California, Los Angeles, CA, United States |
Area:
DNA methylation, cancer, epigeneticsGoogle:
"Shikhar Sharma"Mean distance: 14248.8
Parents
Sign in to add mentorPeter A. Jones | grad student | 2010 | USC | |
(Role of DNA methyltransferases 3A and 3B in inheritance of DNA methylation patterns.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Qiu J, Sharma S, Rollins RA, et al. (2020) The complex role of EZH2 in the tumor microenvironment: opportunities and challenges for immunotherapy combinations. Future Medicinal Chemistry |
Rugo HS, Jacobs I, Sharma S, et al. (2020) The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review. Advances in Therapy |
Kung PP, Bingham P, Brooun A, et al. (2017) Optimization of orally bioavailable enhancer of zeste homolog 2 (EZH2) inhibitors using ligand and property-based design strategies: Identification of development candidate (R)-5,8-dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497). Journal of Medicinal Chemistry |
Vangamudi B, Paul TA, Shah PK, et al. (2015) The SMARCA2/4 ATPase domain surpasses the bromodomain as a drug target in SWI/SNF mutant cancers: Insights from cDNA rescue and PFI-3 inhibitor studies. Cancer Research |
Vangamudi B, Paul T, Shah PK, et al. (2015) Abstract 3528: The SMARCA2/4 catalytic activity, but not the bromodomain, is a drug target in SWI/SNF mutant cancers Cancer Research. 75: 3528-3528 |
Paul TA, Sharma S, Hallin J, et al. (2015) Abstract 3518: Growth inhibition of SCLC cell lines by treatment with LSD1 inhibitors is associated with modulation of neuroendocrine pathways Cancer Research. 75: 3518-3518 |
De Carvalho DD, Sharma S, You JS, et al. (2012) DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell. 21: 655-67 |
Sharma S, Gerke DS, Han HF, et al. (2012) Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells. Epigenetics & Chromatin. 5: 3 |
Sharma S, De Carvalho DD, Jeong S, et al. (2011) Nucleosomes containing methylated DNA stabilize DNA methyltransferases 3A/3B and ensure faithful epigenetic inheritance. Plos Genetics. 7: e1001286 |
Wolff EM, Byun HM, Han HF, et al. (2010) Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. Plos Genetics. 6: e1000917 |